Home › Calculator › GLMD Dividend Calculator 2026
GLMD Dividend DRIP Calculator 2026
350.88% YieldHealthcareGalmed Pharmaceuticals Ltd. · NASDAQ
Price: $0.57 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When GLMD pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your GLMD snowball 📈
$10,000 in GLMD → $34720.24M in 10 years · $2,251,636,617.83/month
About Galmed Pharmaceuticals Ltd. (GLMD) — Dividend Analysis 2026
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.
Compare GLMD with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full GLMD DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GLMD position with:
🌍 GLMD Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold GLMD.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 350.88% | 348.08% | $35,088 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 298.25% | 295.45% | $29,825 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 280.70% | 277.90% | $28,070 / yr |
| 🇬🇧 UK ISA | 0% | 350.88% | 348.08% | $35,088 / yr |
| 🇬🇧 UK Taxable | 8.75% | 320.18% | 317.38% | $32,018 / yr |
| 🇨🇦 TFSA | 0% | 350.88% | 348.08% | $35,088 / yr |
| 🇨🇦 CA Taxable | 25% | 263.16% | 260.36% | $26,316 / yr |
| 🇦🇺 Super (pension) | 15% | 298.25% | 295.45% | $29,825 / yr |
| 🇦🇺 AU Taxable | 30% | 245.62% | 242.82% | $24,562 / yr |
| 🇩🇪 DE Taxable | 26.375% | 258.34% | 255.54% | $25,834 / yr |
| 🇫🇷 FR Taxable | 30% | 245.62% | 242.82% | $24,562 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 GLMD Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 GLMD Dividend Payment Schedule
GLMD pays quarterly — 4 times per year. Next ex-div: TBD.
📊 GLMD vs Healthcare Benchmarks
How GLMD compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GLMD sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ GLMD Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GLMD dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Galmed Pharmaceuticals Ltd. (GLMD) is currently trading at $0.57, 100% below its 52-week high. The current dividend yield is 350.88% based on an annual payout of $2.00 per share.
GLMD (Galmed Pharmaceuticals Ltd.) — 350.88% Dividend Yield Analysis
Galmed Pharmaceuticals Ltd. (GLMD) is a healthcare stock currently trading at $0.57 with a dividend yield of 350.88%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (350.88%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest GLMD News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.